reference/14614634

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14614634

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	17
issn	0022-3085
issueIdentifier	1
pageRange	9-17
publicationName	Journal of Neurosurgery
startingPage	9
bibliographicCitation	Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005 Jul;103(1):9–17. doi: 10.3171/jns.2005.103.1.0009. PMID: 16121967.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bd6cd654acbae4c04064dc87f5e6e0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5dcfb3009ab67cadf9c6c8b16faecbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48486e406bef8d6b9bb7243d121f9db3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c862a74f0538d751946f695e0e3f0398 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c7d94a3d60ed4ca19ec7f55c127acee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37bc0108a6fe54a667ef0b6d808905fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7208b31a3d1b33f0418ff53f8d99c0ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26549613265912bd7d67691a6adf25cf
date	200507
identifier	https://pubmed.ncbi.nlm.nih.gov/16121967 https://doi.org/10.3171/jns.2005.103.1.0009
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5028 https://portal.issn.org/resource/ISSN/0022-3085
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa study
discusses	http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0587498 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0218648 http://id.nlm.nih.gov/mesh/M0499083 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0006497 http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D065130 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D020301Q000517 http://id.nlm.nih.gov/mesh/D020301Q000209 http://id.nlm.nih.gov/mesh/D044022Q000627 http://id.nlm.nih.gov/mesh/D013345Q000150 http://id.nlm.nih.gov/mesh/D004146Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D020301Q000000981 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013777 http://id.nlm.nih.gov/mesh/D013345Q000601 http://id.nlm.nih.gov/mesh/D013345Q000503 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001783Q000502 http://id.nlm.nih.gov/mesh/D011725 http://id.nlm.nih.gov/mesh/D013449 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D002560Q000502 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011859
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8166 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10546 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6892 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44284481 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433095 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9322 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_59dd577145d725309f037ed043ab8fb3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10045

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID473153874 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128483327

Total number of triples: 69.